Multiple Myeloma
Featured Articles
(ASCO) July 25, 2018 - A new “frailty index” predicts overall survival for patients newly diagnosed with multiple myeloma, according to a study published on July 25 in JCO Clinical Cancer Informatics (JCO CCI). This tool is important because frailty is a critical factor in treatment decision-making for many patients with multiple...
Read Article
(Morningstar) July 11, 2018 - Takeda Pharmaceutical Company Limited today announced that the randomized, Phase 3 TOURMALINE-MM3 study met its primary endpoint, demonstrating single-agent oral NINLARO® (ixazomib) as a maintenance therapy resulted in a statistically significant improvement in progression-free survival (PFS) versus placebo.
Read Article
Latest Articles
August 13, 2018
August 13, 2018
August 09, 2018
August 08, 2018
August 07, 2018
July 31, 2018
July 27, 2018
July 26, 2018
View More
News Commentary
Editor Image
14 Mar, 2018 | by Thomas Marsland, MD
Drug pricing and the costs of medications is clearly an ongoing problem. But as...
View Comment
Editor Image
07 Mar, 2018 | by Jeff Patton, M.D.
There are certainly some perverse incentives in medicine but there is a...
View Comment
View More
OBR Green
There are no Multiple Myeloma OBR Green articles.
OBR Blog
There are no Multiple Myeloma blog entries.